{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:49:58Z","timestamp":1757627398488,"version":"3.44.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Ulm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Deferral of non-emergency cardiac interventions is associated with worse clinical outcomes, even post-procedurally. Affected patients show signs of congestive heart failure (CHF) after the waiting time. To identify predictors of CHF with clinical progress during prolonged waiting time, and assess the impact of CHF on the actual intervention date and of the identified baseline predictors in case of deferral on subsequent outcomes. Consecutive patients whose non-emergency cardiac intervention was postponed during the first Covid-19 related lockdown between March 19th and April 30th, 2020 were included (n\u2009=\u2009178). Binary logistic regression analysis was performed to identify predictors of clinically progredient CHF, indicated by an NT-proBNP level of\u2009&gt;\u2009900\u00a0pg\/ml on the actual intervention date in combination with worsening of dyspnea as assessed by NYHA class, emergency heart failure hospitalization, or declining left ventricular ejection fraction (LVEF) during the waiting time. Clinical outcomes were compared to a seasonal control group undergoing such interventions in 2019 as scheduled (n\u2009=\u2009214). 89 of 178 deferred patients (50.0%) had an NT-proBNP level of\u2009&gt;\u2009900\u00a0pg\/ml in combination with clinical symptoms indicating CHF on the actual intervention date. Thereof, repeated data measurement was available for 72 patients, of whom 54 (75%) experienced new-onset or worsening of CHF, while 18 (25%) had stable, pre-existing CHF. Planned transcatheter heart valve intervention was the only independent predictor of CHF with clinical progress (OR 34.632, 95%-CI 3.337\u2013359.404, <jats:italic>p<\/jats:italic>\u2009=\u20090.003). Risk was even higher in patients with planned mitral or tricuspid edge-to-edge-repair (M\/T-TEER) than in those with transcatheter aortic valve replacement (TAVR) (82.4% vs. 40.0%; <jats:italic>p<\/jats:italic>\u2009=\u20090.035 after Bonferroni correction). During the post-procedural 36-month follow-up, rates of emergency hospitalization or death were significantly higher in patients with CHF and time-to event was shorter compared to those without (57.3% vs. 14.0%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001; HR 6.432, 95%-CI 3.476\u201311.868; log rank <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Higher event rates and shorter time-to-event in deferred compared to regularly treated patients after the originally planned intervention date were observed only in those with the predictor scheduled heart valve intervention (83.7% vs. 40.4%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001; HR 4.37, 95%-CI 2.50\u20137.64, log rank <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Deferral of planned transcatheter heart valve intervention, TAVR and especially M\/T-TEER, leads to a highly increased risk of clinically progredient CHF during prolonged waiting time and worse clinical outcomes. Therefore, these procedures should be prioritized and postponement should be avoided.<\/jats:p>","DOI":"10.1038\/s41598-025-16742-7","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T11:39:24Z","timestamp":1756726764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deferral of scheduled transcatheter heart valve interventions strongly increases the risk of congestive heart failure"],"prefix":"10.1038","volume":"15","author":[{"given":"Stefanie","family":"Andre\u00df","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Felbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sascha","family":"d\u2019Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Buckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Rottbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Imhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7733-5261","authenticated-orcid":false,"given":"Tilman","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"16742_CR1","unstructured":"World Health Organisation. Cardiovascular diseases (CVDs), accessed 01 April 2024; www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases (2021)."},{"issue":"3","key":"16742_CR2","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ejhf.2115","volume":"23","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt, B. et al. Universal definition and classification of heart failure: A report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Eur. J. Heart Fail. 23(3), 352\u2013380. https:\/\/doi.org\/10.1002\/ejhf.2115 (2021).","journal-title":"Eur. J. Heart Fail."},{"issue":"8","key":"16742_CR3","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/ejhf.1858","volume":"22","author":"A Groenewegen","year":"2020","unstructured":"Groenewegen, A., Rutten, F. H., Mosterd, A. & Hoes, A. W. Epidemiology of heart failure. Eur. J. Heart Fail. 22(8), 1342\u20131356. https:\/\/doi.org\/10.1002\/ejhf.1858 (2020).","journal-title":"Eur. J. Heart Fail."},{"issue":"18","key":"16742_CR4","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich, P. A. et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines. Circulation 145(18), e895\u2013e1032 (2022).","journal-title":"Circulation"},{"key":"16742_CR5","unstructured":"Malik, A., Brito, D., Vaqar, S., Chhabra, L. Congestive Heart Failure. 2023 Nov 5. In: StatPearls[Internet] (StatPearls Publishing, 2023)."},{"issue":"9","key":"16742_CR6","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","volume":"141","author":"SS Virani","year":"2020","unstructured":"Virani, S. S. et al. American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee heart disease and stroke statistics-2020 update: A report from the American heart association. Circulation 141(9), e139\u2013e596 (2020).","journal-title":"Circulation"},{"issue":"11","key":"16742_CR7","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/ejhf.1594","volume":"21","author":"NR Jones","year":"2019","unstructured":"Jones, N. R., Roalfe, A. K., Adoki, I., Hobbs, F. D. R. & Taylor, C. J. Survival of patients with chronic heart failure in the community: A systematic review and meta-analysis. Eur. J. Heart Fail. 21(11), 1306\u20131325. https:\/\/doi.org\/10.1002\/ejhf.1594 (2019).","journal-title":"Eur. J. Heart Fail."},{"issue":"4","key":"16742_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1161\/CIRCULATIONAHA.108.812172","volume":"119","author":"PS Jhund","year":"2009","unstructured":"Jhund, P. S. et al. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003. Circulation 119(4), 515\u2013529. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.812172 (2009).","journal-title":"Circulation"},{"issue":"2","key":"16742_CR9","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ahj.2007.08.036","volume":"155","author":"DT Ko","year":"2008","unstructured":"Ko, D. T. et al. Life expectancy after an index hospitalization for patients with heart failure: A population-based study. Am. Heart J. 155(2), 324\u2013331. https:\/\/doi.org\/10.1016\/j.ahj.2007.08.036 (2008).","journal-title":"Am. Heart J."},{"key":"16742_CR10","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s00392-024-02380-y","volume":"113","author":"S Andre\u00df","year":"2024","unstructured":"Andre\u00df, S. et al. Deferral of non-emergency cardiac interventions is associated with emergency hospitalizations up to 24 months post-procedure. Clin. Res. Cardiol. 113, 1041\u20131050. https:\/\/doi.org\/10.1007\/s00392-024-02380-y (2024).","journal-title":"Clin. Res. Cardiol."},{"key":"16742_CR11","unstructured":"The European Society for Cardiology. ESC guidance for the diagnosis and management of CV disease during the COVID-19 Pandemic. https:\/\/www.escardio.org\/Education\/COVID-19-and-Cardiology\/ESC-COVID-19-Guidance (2020)."},{"key":"16742_CR12","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00392-022-02032-z","volume":"111","author":"S Andre\u00df","year":"2022","unstructured":"Andre\u00df, S. et al. Deferral of non-emergency cardiac procedures is associated with increased early emergency cardiovascular hospitalizations. Clin. Res. Cardiol. 111, 1121\u20131129. https:\/\/doi.org\/10.1007\/s00392-022-02032-z (2022).","journal-title":"Clin. Res. Cardiol."},{"issue":"19","key":"16742_CR13","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1016\/j.jacc.2018.02.071","volume":"71","author":"MK York","year":"2018","unstructured":"York, M. K. et al. B-Type natriuretic peptide levels and mortality in patients with and without heart failure. J. Am. Coll. Cardiol. 71(19), 2079\u20132088. https:\/\/doi.org\/10.1016\/j.jacc.2018.02.071 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"27","key":"16742_CR14","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski, P. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 37(27), 2129\u20132200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128 (2016).","journal-title":"Eur. Heart J."},{"key":"16742_CR15","doi-asserted-by":"publisher","first-page":"1091309","DOI":"10.3389\/fcvm.2023.1091309","volume":"10","author":"J Curio","year":"2023","unstructured":"Curio, J., Beneduce, A. & Giannini, F. Transcatheter mitral and tricuspid interventions\u2014the bigger picture: Valvular disease as part of heart failure. Front. Cardiovasc. Med. 10, 1091309. https:\/\/doi.org\/10.3389\/fcvm.2023.1091309 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"16742_CR16","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","volume":"379","author":"GW Stone","year":"2018","unstructured":"Stone, G. W. et al. Transcatheter mitral-valve repair in patients with heart failure. N. Engl. J. Med. 379, 2307\u20132318. https:\/\/doi.org\/10.1056\/NEJMoa1806640 (2018).","journal-title":"N. Engl. J. Med."},{"key":"16742_CR17","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jcmg.2020.12.015","volume":"14","author":"N Karam","year":"2021","unstructured":"Karam, N. et al. Impact of right ventricular dysfunction on outcomes after transcatheter edge-to-edge repair for secondary mitral regurgitation. JACC Cardiovasc. Imaging 14, 768\u2013778. https:\/\/doi.org\/10.1016\/j.jcmg.2020.12.015 (2021).","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"18","key":"16742_CR18","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.jacc.2010.02.005","volume":"55","author":"ED Peterson","year":"2010","unstructured":"Peterson, E. D. et al. NCDR registry participants. Contemporary mortality risk prediction for percutaneous coronary intervention: Results from 588 398 procedures in the national cardiovascular data registry. J. Am. Coll. Cardiol. 55(18), 1923\u20131932. https:\/\/doi.org\/10.1016\/j.jacc.2010.02.005 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"16742_CR19","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.jacc.2011.03.072","volume":"58","author":"JL Januzzi","year":"2011","unstructured":"Januzzi, J. L. et al. Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction. J. Am. Coll. Cardiol. 58, 1881\u20131889. https:\/\/doi.org\/10.1016\/j.jacc.2011.03.072 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"16742_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2174\/1568026611313020002","volume":"13","author":"V Panagopolou","year":"2013","unstructured":"Panagopolou, V. et al. NTproBNP: An important biomarker in cardiac diseases. Curr. Top. Med. Chem. 13(2), 82\u201394. https:\/\/doi.org\/10.2174\/1568026611313020002 (2013).","journal-title":"Curr. Top. Med. Chem."},{"issue":"3","key":"16742_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/00008483-199505000-00007","volume":"15","author":"C Foster","year":"1995","unstructured":"Foster, C. et al. Time course of recovery during cardiac rehabilitation. J. Cardiopulm. Rehabil. 15(3), 209\u2013215. https:\/\/doi.org\/10.1097\/00008483-199505000-00007 (1995).","journal-title":"J. Cardiopulm. Rehabil."},{"key":"16742_CR22","doi-asserted-by":"publisher","first-page":"100553","DOI":"10.1016\/j.ijcha.2020.100553","volume":"29","author":"H Rudolf","year":"2020","unstructured":"Rudolf, H. et al. NT-proBNP for risk prediction of cardiovascular events and all-cause mortality: The getABI-study. IJC Heart Vasc. 29, 100553. https:\/\/doi.org\/10.1016\/j.ijcha.2020.100553 (2020).","journal-title":"IJC Heart Vasc."},{"key":"16742_CR23","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/eurheartj\/ehi63","volume":"27","author":"JL Januzzi","year":"2006","unstructured":"Januzzi, J. L. et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: An international pooled analysis of 1256 patients. Eur. Heart J. 27, 330\u2013337. https:\/\/doi.org\/10.1093\/eurheartj\/ehi63 (2006).","journal-title":"Eur. Heart J."},{"key":"16742_CR24","doi-asserted-by":"publisher","first-page":"e002293","DOI":"10.1136\/openhrt-2023-002293","volume":"10","author":"S Andre\u00df","year":"2023","unstructured":"Andre\u00df, S. et al. Predictors of worse outcome after postponing non-emergency cardiac interventions during the COVID-19 pandemic. Open Heart 10, e002293. https:\/\/doi.org\/10.1136\/openhrt-2023-002293 (2023).","journal-title":"Open Heart"},{"key":"16742_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjon.2021.06.006","author":"DR Freno","year":"2021","unstructured":"Freno, D. R. et al. Modeling the impact of delaying TAVR for the treatment of aortic stenosis in the era of Covid-19. JTCVS Open. https:\/\/doi.org\/10.1016\/j.xjon.2021.06.006 (2021).","journal-title":"JTCVS Open."},{"key":"16742_CR26","doi-asserted-by":"publisher","first-page":"e2020402","DOI":"10.1001\/jamanetworkopen.2020.20402","volume":"3","author":"C Ryffel","year":"2020","unstructured":"Ryffel, C. et al. Mortality, stroke, and hospitalization associated with deferred vs expedited aortic valve replacement in patients referred for symptomatic severe aortic stenosis during the COVID-19 pandemic. JAMA Netw. Open 3, e2020402. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.20402 (2020).","journal-title":"JAMA Netw. Open"},{"key":"16742_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1161\/CIRCULATIONAHA.117.033432","volume":"138","author":"G Elbaz-Greener","year":"2018","unstructured":"Elbaz-Greener, G. et al. Temporal trends and clinical consequences of wait times for transcatheter aortic valve replacement: A population-based study. Circulation 138, 483\u2013493. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.033432 (2018).","journal-title":"Circulation"},{"key":"16742_CR28","doi-asserted-by":"publisher","first-page":"e2019801","DOI":"10.1001\/jamanetworkopen.2020.19801","volume":"3","author":"R Ro","year":"2020","unstructured":"Ro, R. et al. Characteristics and outcomes of patients deferred for transcatheter aortic valve replacement because of covid-19. JAMA Netw. Open 3, e2019801. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.19801 (2020).","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"16742_CR29","doi-asserted-by":"publisher","first-page":"100934","DOI":"10.1016\/j.cpcardiol.2021.100934","volume":"47","author":"K Obi","year":"2021","unstructured":"Obi, K. et al. Structural heart interventions during Covid-19. Curr. Probl. Cardiol. 47(2), 100934. https:\/\/doi.org\/10.1016\/j.cpcardiol.2021.100934 (2021).","journal-title":"Curr. Probl. Cardiol."},{"key":"16742_CR30","first-page":"371","volume":"93","author":"BH Grimard","year":"2016","unstructured":"Grimard, B. H., Safford, R. E. & Burns, E. L. Aortic stenosis: Diagnosis and treatment. Am. Fam. Physician 93, 371\u2013378 (2016).","journal-title":"Am. Fam. Physician"},{"key":"16742_CR31","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.athoracsur.2014.06.040","volume":"98","author":"SC Malaisrie","year":"2014","unstructured":"Malaisrie, S. C. et al. Mortality while waiting for aortic valve replacement. Ann. Thoracic Surg. 98, 1564\u20131571. https:\/\/doi.org\/10.1016\/j.athoracsur.2014.06.040 (2014).","journal-title":"Ann. Thoracic Surg."},{"key":"16742_CR32","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.jcin.2021.03.007","volume":"14","author":"J Shuhaiber","year":"2021","unstructured":"Shuhaiber, J. & Nathanson, B. H. Comments on evaluating out-of-hospital 30-day mortality after transfemoral transcatheter aortic valve replacement. JACC Cardiovasc. Interv. 14, 1039\u20131040. https:\/\/doi.org\/10.1016\/j.jcin.2021.03.007 (2021).","journal-title":"JACC Cardiovasc. Interv."},{"key":"16742_CR33","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ccd.29433","volume":"97","author":"R Moreno","year":"2021","unstructured":"Moreno, R. et al. Consequences of canceling elective invasive cardiac procedures during Covid-19 outbreak. Catheter. Cardiovasc. Interv. 97, 927\u2013937. https:\/\/doi.org\/10.1002\/ccd.29433 (2021).","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"7","key":"16742_CR34","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.cjca.2020.12.012","volume":"37","author":"D Messika-Zeitoun","year":"2021","unstructured":"Messika-Zeitoun, D. et al. Management and outcome of patients admitted with tricuspid regurgitation in France. Can. J. Cardiol. 37(7), 1078\u20131085. https:\/\/doi.org\/10.1016\/j.cjca.2020.12.012 (2021).","journal-title":"Can. J. Cardiol."},{"issue":"11","key":"16742_CR35","doi-asserted-by":"publisher","first-page":"e009297","DOI":"10.1161\/CIRCINTERVENTIONS.120.009297","volume":"13","author":"O Albassam","year":"2020","unstructured":"Albassam, O. et al. Increasing wait-time-mortality for severe aortic valve stenosis: A population-level study of the transition in practice from surgical aortic valve replacement to transcatheter aortic valve replacement. Circ. Cardiovasc. Interv. 13(11), e009297. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.120.009297 (2020).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"16742_CR36","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s10198-017-0941-3","volume":"19","author":"A Ribera","year":"2018","unstructured":"Ribera, A. et al. The impact of waiting for intervention on costs and effectiveness: The case of transcatheter aortic valve replacement. Eur. J. Health Econ. 19, 945\u2013956. https:\/\/doi.org\/10.1007\/s10198-017-0941-3 (2018).","journal-title":"Eur. J. Health Econ."},{"issue":"3","key":"16742_CR37","doi-asserted-by":"publisher","first-page":"361","DOI":"10.23736\/S1973-9087.20.06361-3","volume":"56","author":"S Negrini","year":"2020","unstructured":"Negrini, S. et al. Up to 2.2 million people experiencing disability suffer collateral damage each day of COVID-19 lockdown in Europe. Eur. J. Phys. Rehabil. Med. 56(3), 361\u2013365 (2020).","journal-title":"Eur. J. Phys. Rehabil. Med."},{"issue":"5","key":"16742_CR38","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.3390\/ijerph20053825","volume":"20","author":"E Olmastroni","year":"2023","unstructured":"Olmastroni, E., Galimberti, F., Tragni, E., Catapano, A. L. & Casula, M. Impact of COVID-19 pandemic on adherence to chronic therapies: A systematic review. Int. J. Environ. Res. Public Health 20(5), 3825. https:\/\/doi.org\/10.3390\/ijerph20053825 (2023).","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"23","key":"16742_CR39","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1056\/NEJMp2005835","volume":"382","author":"S Keesara","year":"2020","unstructured":"Keesara, S., Jonas, A. & Schulman, K. Covid-19 and health care\u2019s digital revolution. N. Engl. J. Med. 382(23), e82. https:\/\/doi.org\/10.1056\/NEJMp2005835 (2020).","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"16742_CR40","doi-asserted-by":"publisher","first-page":"e045343","DOI":"10.1136\/bmjopen-2020-045343","volume":"11","author":"R Moynihan","year":"2021","unstructured":"Moynihan, R. et al. Impact of COVID-19 pandemic on utilisation of healthcare services: A systematic review. BMJ Open 11(3), e045343. https:\/\/doi.org\/10.1136\/bmjopen-2020-045343 (2021).","journal-title":"BMJ Open"},{"issue":"18","key":"16742_CR41","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.jacc.2020.03.021","volume":"75","author":"FGP Welt","year":"2020","unstructured":"Welt, F. G. P. et al. American college of cardiology\u2019s interventional council and the society for cardiovascular angiography and interventions. Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: From the ACC\u2019s interventional council and SCAI. J. Am. Coll. Cardiol. 75(18), 2372\u20132375. https:\/\/doi.org\/10.1016\/j.jacc.2020.03.021 (2020).","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16742-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16742-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16742-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T01:56:51Z","timestamp":1757469411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16742-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16742"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16742-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"15 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32151"}}